Signal active
Bio
James Wang is a co-founder of Lioness, currently serving as CTO and COO. His specialities management, software development, and statistical analysis and learning (AI/machine learning). Previously, he spearheaded the launch announcement and branding for Google X's Makani project pilot in Hawaii, led a team of analysts at Bridgewater Associates, and co-founded and managed a consulting group specializing in microfinance in the developing world.
James holds an MBA from UC Berkeley where he was a Jack Larson Fellow in Entrepreneurship, a BA with Honors from Dartmouth, and is an MS Computer Science candidate at Georgia Tech. He also holds a Data Science Specialization from the John Hopkins Bloomberg School of Public Health and completed the course track for a PhD Designated Emphasis in Computational Sciences and Engineering at Berkeley.
Location
Berkeley, California, United States, North America
Social
Primary Organization
2016
59
11
4
11-50
Biotechnology, Food and Beverage, Health Care, Computer Vision, Medical Device, Robotics, Advanced Materials, Clean Energy, Construction, Battery
Jobs history
1
Board Member
2022 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
James Wang is the General Partner at Creative Ventures, based in United States, North America. With a background in Biotechnology, James Wang has a rich history of leadership and innovation. James Wang studied BA Philosophy and Economics @ Dartmouth College. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
3
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Feb 02, 2021 | C. Light Technologies | Seed Round - C. Light Technologies | Creative Ventures | 4.1M |
Jul 21, 2022 | - | Seed Round - Oncoustics AI | Creative Ventures | 5.0M |
Aug 01, 2022 | OncoPrecision | Seed Round - OncoPrecision | Creative Ventures | 3.3M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.